ASHLEY WALDREP: Open Payments
NPI 1508394149 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,053 in 47 payments from 27 companies in 2025. Trend: 2023 $94 · 2024 $1,700 · 2025 $1,053
Food & beverage: $1,000Education: $53
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $159 |
| Kite Pharma, Inc. | 2 | $95 |
| ABBVIE INC. | 4 | $84 |
| Genentech USA, Inc. | 3 | $56 |
| Daiichi Sankyo Inc. | 3 | $55 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Genentech, Inc. | 1 | $53 |
| EMD Serono, Inc. | 1 | $49 |
| SERVIER PHARMACEUTICALS LLC | 2 | $43 |
| Aveo Pharmaceuticals, Inc. | 2 | $35 |
Products named: KISQALI, Yescarta, EPKINLY, KEYTRUDA, Enhertu, FOTIVDA, MI CANCER SEEK, Vyloy.
Industry payments across NE — which companies pay providers there.
